Journal article
Impact of sepsis on CD4 T cell immunity
Journal of leukocyte biology, Vol.96(5), pp.767-777
11/2014
DOI: 10.1189/jlb.5MR0114-067R
PMCID: PMC4197564
PMID: 24791959
Abstract
Sepsis remains the primary cause of death from infection in hospital patients, despite improvements in antibiotics and intensive-care practices. Patients who survive severe sepsis can display suppressed immune function, often manifested as an increased susceptibility to (and mortality from) nosocomial infections. Not only is there a significant reduction in the number of various immune cell populations during sepsis, but there is also decreased function in the remaining lymphocytes. Within the immune system, CD4 T cells are important players in the proper development of numerous cellular and humoral immune responses. Despite sufficient clinical evidence of CD4 T cell loss in septic patients of all ages, the impact of sepsis on CD4 T cell responses is not well understood. Recent findings suggest that CD4 T cell impairment is a multipronged problem that results from initial sepsis-induced cell loss. However, the subsequent lymphopenia-induced numerical recovery of the CD4 T cell compartment leads to intrinsic alterations in phenotype and effector function, reduced repertoire diversity, changes in the composition of naive antigen-specific CD4 T cell pools, and changes in the representation of different CD4 T cell subpopulations (e.g., increases in Treg frequency). This review focuses on sepsis-induced alterations within the CD4 T cell compartment that influence the ability of the immune system to control secondary heterologous infections. The understanding of how sepsis affects CD4 T cells through their numerical loss and recovery, as well as function, is important in the development of future treatments designed to restore CD4 T cells to their presepsis state.
Details
- Title: Subtitle
- Impact of sepsis on CD4 T cell immunity
- Creators
- Javier Cabrera-Perez - Microbiology, Immunology, and Cancer Biology Graduate Program Medical Scientist Training ProgramStephanie A Condotta - Department of Pathology andVladimir P Badovinac - Department of Pathology and Interdisciplinary Program in Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USAThomas S Griffith - Microbiology, Immunology, and Cancer Biology Graduate Program Center for Immunology, and Department of Urology, University of Minnesota Medical School, Minneapolis, Minnesota, USA; Minneapolis Veterans Administration Health Care System, Minneapolis, Minnesota, USA; and tgriffit@umn.edu
- Resource Type
- Journal article
- Publication Details
- Journal of leukocyte biology, Vol.96(5), pp.767-777
- DOI
- 10.1189/jlb.5MR0114-067R
- PMID
- 24791959
- PMCID
- PMC4197564
- NLM abbreviation
- J Leukoc Biol
- ISSN
- 0741-5400
- eISSN
- 1938-3673
- Publisher
- United States
- Grant note
- P30 CA077598 / NCI NIH HHS AI83286 / NIAID NIH HHS I01 BX001324 / BLRD VA R01 AI083286 / NIAID NIH HHS T32 GM008244 / NIGMS NIH HHS T32 AI007313 / NIAID NIH HHS
- Language
- English
- Date published
- 11/2014
- Academic Unit
- Microbiology and Immunology; Pathology
- Record Identifier
- 9984047888702771
Metrics
20 Record Views